{"schema_version":"secwatch.filing_event.v1","accession":"0001522767-26-000164","form_type":"8-K","ticker":"MRMD","cik":"0001522767","company_name":"MARIMED INC.","filed_at":"2026-08-12T21:07:15+00:00","discovered_at":"2026-08-12T21:08:00.624892+00:00","generated_at":"2026-08-12T21:08:55.227116+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"MariMed Q2 2026 revenue up 6% to $41.9M; net loss widens to $3.6M","bullets":["Revenue of $41.9M in Q2 2026, up 6% from $39.5M in Q2 2025; H1 revenue $81.4M vs $77.4M.","GAAP net loss widened to $3.6M in Q2 vs $1.4M a year ago; non-GAAP net loss $2.4M vs $0.3M profit.","Non-GAAP adjusted EBITDA fell to $3.9M (9% margin) from $4.8M (12% margin) in Q2 2025.","GAAP gross margin 39% vs 40%; non-GAAP gross margin 40% vs 42%, down YoY."],"urls":{"canonical":"https://secwatch.observer/filing/0001522767-26-000164","json":"https://secwatch.observer/filing/0001522767-26-000164.json","markdown":"https://secwatch.observer/filing/0001522767-26-000164.md","text":"https://secwatch.observer/filing/0001522767-26-000164.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1522767/000152276726000164/0001522767-26-000164-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1522767/000152276726000164/mrmd-20260812.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-12T21:08:55.227116+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}